check_circleStudy Completed
Infection
Bayer Identifier:
Trial_100225
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Ciprofloxacin (either oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) or a non-quinolone antibiotic (either oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) in the treatment of pediatric patients with infectious diagnoses
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
BothAge
2 - 16 YearsTrial summary
Enrollment Goal
994Trial Dates
April 2000 - June 2003Phase
Phase 3Could I Receive a placebo
N/AProducts
Cipro (Ciprofloxacin, BAYQ3939)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A